Skeletal muscle regeneration is mainly enabled by a population of adult stem cells known as satellite cells. Satellite cells have been shown to be indispensable for adult skeletal muscle repair and regeneration. In the last two decades, other stem/progenitor cell populations resident in the skeletal muscle interstitium have been identified as "collaborators" of satellite cells during regeneration. They also appear to have a key role in replacing skeletal muscle with adipose, fibrous or bone tissue in pathological conditions.
Introduction
The primary role of skeletal muscle is to generate movement, maintain posture and support soft tissues, contributing also to body metabolism and temperature control. Muscle contraction and force generation is mediated by the interaction of actin and myosin proteins within the complex sarcomere unit. Aligned sarcomeres units make myofibrils, bundles of which span the length of each muscle fibre (myofibre). In turn, numerous bundles of myofibres make up each muscle [1] . These multinucleated, syncytial cells are formed during the process of myogenesis [2] . However, as myofibre nuclei are post-mitotic they are unable to contribute to growth and repair [3] .
It is generally accepted that satellite cells, a population of muscle stem cells that reside beneath the basal lamina of myofibres, are responsible for the regenerative capacity of adult skeletal muscle. Satellite cells are a heterogeneous group of stem cells of embryonic somitic origin that normally reside in a quiescent state until activated by damage or growth signals [4] [5] [6] . The vast majority of mammalian satellite cells can be identified by expression of the paired-box transcription factor Pax7, which is satellite cellspecific in skeletal muscle. Many other proteins mark the majority of satellite cells, including Integrin-α7, M-Cadherin, Caveolin-1, CD56/NCAM, CD29/Integrin-β1, Syndecan 3 and 4 (reviewed in [4, 7, 8] ). However, these markers are also expressed by other populations of cells within the muscle tissue, so they should be used in combination to ensure specificity (Table 1) . Once activated, satellite cells undergo defined proliferation/differentiation or self-renewal processes to contribute either to tissue repair or replenishment of their stem cell pool [9] [10] [11] .
Other stem/progenitor cell populations present in the adult skeletal muscle ( Figure   1 ) have been identified as capable to contribute to or to modulate muscle regeneration. Here, we provide an overview and discuss the role and known functions of these non-satellite cells residing in adult skeletal muscle, focusing on studies published in the last decade. Additional information on other cell populations (e.g. muscle resident "side population") can be found in Table 1 . We direct the reader to other review articles for a more comprehensive analysis of developmental origins of muscle stem cells, molecular networks, functions and use in cell-based therapies [4, 8, [12] [13] [14] [15] [16] [17] [18] . We define satellite cells as a Pax7+ cells located underneath the basal lamina, and interstitial cells as those resident between myofibres and outside their basal lamina. This will help to distinguish satellite cells from occasional Pax7+ cells in the muscle interstitium, which could either be separate interstitial stem cell populations or satellite cells trapped outside the basal lamina following myofibre remodelling (Paolo Bianco, personal communication).
Pericytes and mesoangioblasts
Pericytes are a heterogeneous group of contractile cells which encircle the endothelium of micro-vessels, first described by Rouget in 1873 [19] . Present in all vascularised tissues, pericytes regulate blood vessel growth, homeostasis and permeability, in addition to other tissue-specific roles (reviewed in [14] ). In skeletal muscle, blood vessels run adjacent to myofibres resulting in the close association and likely cross-talk between pericytes and satellite cells [20] [21] [22] . Indeed, pericytes have been shown to regulate post-natal myogenesis and satellite cell quiescence [23] . At rest, pericytes are embedded within the 5 vascular basement membrane, which separates them from other periendothelial mesenchymal cells [14, 22] .
A major limitation in the study of muscle pericytes is the lack of a specific marker to distinguish them from other satellite and non-satellite cell populations (reviewed in [12, 14] [28] . The extent to which these three populations overlap is currently unknown. Interestingly, a recent report has confirmed that human pericytes isolated from skeletal and smooth muscle tissues are functionally different, and that only the pericytes isolated from skeletal muscle are able to contribute to skeletal muscle regeneration [29] .
Mesoangioblast is a term for vessel-associated mesodermal stem/progenitor cells expanded in vitro, initially utilised for cells isolated from the murine embryonic dorsal aorta [30] . Mesoangioblast markers depend on the stage of development at which they are isolated; embryonic mesoangioblasts deriving from the dorsal aorta express mostly endothelial markers such as VE-cadherin and CD34 [31, 32] . Cells similar to embryonic mesoangioblasts can be derived from adult skeletal muscle pericytes, expressing varying degrees of pericyte markers such as neuro-glial 2 proteoglycan (NG2), platelet-derived 6 growth factors receptor beta (PDGFR-β), alpha smooth-muscle actin (αSMA), desmin and, most importantly, TNAP, whilst being negative for endothelial and myogenic makers [14, 21, [24] [25] [26] . Mesoangioblasts also express Pw1 (see below), which was shown to be essential for proper stem cell function [33] . To simplify relationships with specific resident skeletal muscle cells, mesoangioblasts are considered as the activated progeny of pericytes in the same way that myoblasts are the activated progeny of satellite cells Muscle-resident fibroblasts are the cell population classically thought to be responsible for extracellular matrix remodelling and accumulation of fibrosis in pathological conditions such as muscular dystrophies. However, they also support healthy myogenesis, as ablation of transcription factor 4 (Tcf4)-positive muscle fibroblasts has been shown to impair muscle regeneration through premature differentiation of satellite cells and reduction of the satellite cell pool [60] . Interestingly, Tcf4 is expressed by both fibroblasts and mesenchymal progenitors, making it difficult to decipher the individual roles of each cell type using current experimental strategies. Specifically, whether some of the functions currently accounted to fibroblasts may be in fact performed by different populations of mesenchymal progenitors (and vice versa). Additionally, in chronic injury models, resident myoblasts, endothelial and hematopoietic cells have been shown to trans-differentiate into fibroblastic cells, advancing dystrophic pathology [60, 61] , with a mechanism of transdifferentiation that occurs through an intermediate mesenchymal stem cell step [61] . Therefore, the definition of which cells are fibroblast or mesenchymal progenitors and their origin may be even more difficult than expected.
Besides their role during muscle regeneration and chronic pathologies, resident mesenchymal progenitors may have a role in skeletal muscle homeostasis. They secrete a number of Wnt ligands and myokines such as IL-6 [47,48,52]. Moreover, it has been demonstrated that interstitial mesenchymal cells are the main producers of collagen VI in resting muscle [62] . Collagen VI fibres are abundant in the endomysium of skeletal muscle and are a regular component of the satellite cell niche [63] . Mutations in collagen VI encoding genes cause several diseases associated with muscle weakness in humans [64, 65] , and collagen VI deficient mice show myofibre degeneration, reduced strength and deficient satellite cell self-renewal [63, [66] [67] [68] . Interestingly, mesenchymal progenitors of synovial origin secreted collagen VI when engrafted into muscle [69] , indicating that this may be one of the functions of muscle-resident mesenchymal progenitors.
PW1+ interstitial cells
In 2010, Mitchell et al. isolated a Pax7-non-satellite cell muscle-resident population located in the skeletal muscle interstitial space and capable of myogenic differentiation [18, 70] . Apart from their location, these cells are characterised by the expression of the PW1/paternally expressed gene 3 (Peg3), and were named as PICs (PW1+ interstitial cells). In addition, PICs were mostly Sca1+ and CD34+. Lineage tracing experiments demonstrated that PICs do not share the same embryonic origin of satellite cells, and have increased potency, since they are capable to generate smooth and skeletal muscle cells and adipocytes [70] .
Interestingly, satellite cells and mesoangioblasts also express PW1 [32, 33, 70] . Another report using a PW1 reporter mouse demonstrated that the combination of PW1, Sca1 and PDGFRα markers may be used to separate all the different stem cell populations in skeletal muscle [71] . Using this isolation strategy, the PW1+/Sca1+/PDGFRα+ cells are the most abundant subpopulation and comprise the totality of the fibro-adipogenic mesenchymal progenitors with pro-adipogenic potential. Interestingly, this population is similar to the recently described resident brown adipocyte progenitors in the skeletal muscle which were isolated also with the Sca1 marker [72] . PW1-/Sca1+ cells were also functionally similar to the FAPs/MPs, though just with pro-fibrotic potential. In the referred study, this is the only cell subpopulation having a fibroblastic fate. It is therefore tempting to propose that fibro-adipogenic mesenchymal progenitors may be a heterogeneous population of muscle-resident Sca1+ cells that upon pro-fibrotic environmental cues (e.g. TGFβ) will turn into fibroblastic cells, or upon still poorly characterised signals, will acquire PW1 expression and become adipogenic. The PW1+/Sca1+/PDGFRα-population comprises a small group of cells with myogenic potential but negative for Pax7, defined by the authors as "non-satellite cell progenitors with myogenic potential", although they hold some pro-adipogenic potential in vitro. These cells may account for the Sca1+ primary myoblast subpopulations described in some reports in the early 2000s [73] [74] [75] [76] [77] . Finally, the PW1+/Sca1-/PDGFRα-subpopulation included Pax7+ satellite cells and Pax7-cells which were positive for adult myogenic pericyte markers (e.g. NG2+/PDGFRβ+/Myf5-).
Interestingly, PW1 is expressed in pericyte-derived mouse and human mesoangioblasts, where it regulates their myogenic ability and migration capacity [33] .
CD133+ cells

CD133 (Prominin 1) was identified as a surface marker of both neural and haematopoietic
stem and progenitor cells [78] , and its expression has been used to characterise a population of human blood and muscle-derived myogenic stem cells. A small fraction of adult peripheral blood cells expressing CD133 was initially shown to display myogenic potential [79] . Muscle-resident human CD133+ cells are found both in the muscle interstitium and underneath the basal lamina of myofibers, co-expressing Pax7 [80] . When expanded in vitro, CD133+ preparations contained a heterogeneous population of cells expressing myoblast, pericyte and mesenchymal genes [80, 81] . Additionally, expression of CD133 is unstable in culture and influenced by culture media; a thorough expression analysis has not been performed on freshly isolated cells due to their rarity [80] [81] [82] . When injected intramuscularly, human CD133+ cells effectively engraft in the muscle and contribute to myogenesis with a proportion entering the satellite cell compartment [80] [81] [82] .
Transplanted human CD133+/Pax7+ cells are functional, and capable of regenerating mouse muscle following injury [80] . Taken together, the variability of genes and anatomical location implies that CD133-positivity may distinguish a heterogeneous set of stem cells with high myogenic capacity. This makes them an interesting candidate for cellular therapies and indeed they were tested in a pilot, phase I autologous clinical study for Duchenne muscular dystrophy based upon intramuscular transplantation without genetic correction [83] . However, whether the proportion of cells that extravasates and engrafts into muscles downstream of the injection site derives from the population expressing pericyte markers or whether the CD133+/Pax7+ population is able to be safely injected systemically is currently unknown. Although there have been no reports on the contribution of mouse CD133+ cells to skeletal muscle regeneration (probably due to technical reasons), the use of reporter mouse models for CD133 expression in other stem cell niches [84] , may allow future lineage-tracing studies in murine skeletal muscle.
Concluding remarks and future prospects
Adult muscle growth and regeneration is fuelled by satellite cells. However, a growing milieu of interstitial stem or progenitor cells have been described both in resting and regenerating skeletal muscle, which are able to crosstalk with satellite cells, myoblasts, Moreover, there is an urgent need to improve the characterisation and distinction of the different populations of muscle interstitial progenitors, in order to determine whether particular cell types identified in different studies might actually be analogous and to find 13 out which of them should be enhanced (or repressed) to foster efficient myogenesis. In the near future, advanced flow cytometry techniques such as spectral flow cytometry [86, 87] or flow cytometry coupled with mass spectrometry (mass cytometry or CyTOF) [88, 89] which able to discriminate between many factors at the same time, could allow researchers to answer these questions.
A question likely to arise from this in-depth analysis is when does the differential expression of markers correspond to a subpopulation, or to a separate progenitor The majority of studies describing interstitial muscle stem cells in healthy and pathological tissue have been performed in rodents. Differences in marker expression between species are well documented in satellite cells (reviewed in [7] ) and the field is now gradually improving the knowledge on the human satellite cell niche, their markers and properties [91] . Similar characterization efforts are being done for human mesenchymal progenitors [56] . Therefore, it is crucial to identify and characterise the 14 comparable interstitial muscle stem cell populations in human muscle to the well-known rodent ones, in order to maximise therapeutic relevance.
Finally, a thorough characterisation of the different subpopulations of muscle satellite cells and interstitial progenitors may enable the development of next-generation protocols to derive them from human pluripotent stem cells [92] for drug screening, tissue engineering and cell therapies of skeletal muscle disorders. 
